Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

ioflubenzamide I-131

An iodine 131-radiolabeled small-molecule benzamide compound with potential antineoplastic activity. The benzamide moiety of ioflubenzamide I-131 binds to melanin, selectively delivering a cyotoxic dose of gamma and beta radiation to melanin-expressing tumor cells. Melanin pigments, polymer derivatives of the amino acid tyrosine, are over-expressed in approximately 40% of melanomas.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	131-I-MIP-1145 iodine I 131 MIP-1145
Chemical structure:	N-(4-(2-(diethylamino)ethylcarbamoyl)-2-iodo-5-methoxyphenyl)benzo[d][1,3]dioxole-5 carboxamide; N-(2-diethylamino-ethyl)-4-(4-F-benzamido)-5-iodo-2-methoxy-benzamide

ioflubenzamide I-131

Search NCI's Drug Dictionary